Cargando…
Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: Risk, outcome, vaccination, and beyond
Autores principales: | Mahmoudi, Hamidreza, Patsatsi, Aikaterini, Murrell, Dedee F., Tavakolpour, Soheil, Daneshpazhooh, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396300/ https://www.ncbi.nlm.nih.gov/pubmed/36017004 http://dx.doi.org/10.3389/fmed.2022.987534 |
Ejemplares similares
-
Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume II
por: Patsatsi, Aikaterini, et al.
Publicado: (2023) -
Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus
por: Patsatsi, Aikaterini, et al.
Publicado: (2021) -
Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
por: Tavakolpour, Soheil, et al.
Publicado: (2019) -
Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab
por: Alaeen, Hoorieh, et al.
Publicado: (2019) -
Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: A 10-year experience in a skin hospital
por: Nili, Ali, et al.
Publicado: (2020)